Pimafucin, 20 mg/g, cream
(Natamycin)
Pimafucin cream contains natamycin, an antifungal antibiotic from the polyene group for topical use.
Natamycin acts locally and is not absorbed through the skin or mucous membranes.
Pimafucin cream is indicated for the treatment of skin and mucous membrane infections caused by Candida albicansyeast.
Before starting to use Pimafucin, the patient should discuss it with their doctor or pharmacist.
The patient should tell their doctor or pharmacist about all medicines they are taking or have recently taken, as well as any medicines they plan to use.
Interactions with other medicines are not known.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Pimafucin does not affect the ability to drive or use machines.
Pimafucin containscetyl stearyl alcohol, propylene glycol, and methyl and propyl parahydroxybenzoates.
Due to the presence of cetyl stearyl alcohol, the medicine may cause local skin reactions (e.g., contact dermatitis).
Due to the presence of propylene glycol, the medicine may cause skin irritation.
Due to the presence of methyl and propyl parahydroxybenzoates, the medicine may cause allergic reactions (possible late reactions).
This medicine should always be used as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist.
Pimafucin cream is usually applied to the affected areas 1 to 4 times a day.
Treatment usually lasts from 2 to 3 weeks.
There are no reports of overdose with this medicine.
In case of any further doubts about using this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Pimafucin can cause side effects, although not everybody gets them.
Rare side effects (may affect up to 1 in 1000 people):
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
PL-02 222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Reporting side effects will help gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and tube after: {EXP}.
The expiry date refers to the last day of the month.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment .
Pimafucin is a white to light yellow cream.
The packaging contains 30 g of cream.
Responsible entity:
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Germany
Manufacturer:
Temmler Italia S.R.L.
Via Delle Industrie 2
20061 Carugate (MI)
Italy
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.